nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—Nucleic Acid Synthesis Inhibitors—Azathioprine—systemic lupus erythematosus	0.495	1	CiPCiCtD
Cytarabine—POLB—systemic lupus erythematosus	0.351	1	CbGaD
Cytarabine—ABCC10—Cyclosporine—systemic lupus erythematosus	0.0499	0.456	CbGbCtD
Cytarabine—ABCC10—Methotrexate—systemic lupus erythematosus	0.0264	0.241	CbGbCtD
Cytarabine—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00485	0.0443	CbGbCtD
Cytarabine—CYP3A4—Dapsone—systemic lupus erythematosus	0.00424	0.0387	CbGbCtD
Cytarabine—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00368	0.0336	CbGbCtD
Cytarabine—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00368	0.0336	CbGbCtD
Cytarabine—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00316	0.0288	CbGbCtD
Cytarabine—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00311	0.0284	CbGbCtD
Cytarabine—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00295	0.0269	CbGbCtD
Cytarabine—CYP3A4—Prednisone—systemic lupus erythematosus	0.00294	0.0268	CbGbCtD
Cytarabine—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00279	0.0254	CbGbCtD
Cytarabine—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00184	0.0167	CbGbCtD
Cytarabine—DCTD—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00129	0.715	CbGdCrCtD
Cytarabine—POLB—nephron tubule—systemic lupus erythematosus	0.00104	0.0316	CbGeAlD
Cytarabine—POLB—skin of body—systemic lupus erythematosus	0.000969	0.0294	CbGeAlD
Cytarabine—POLB—cortex of kidney—systemic lupus erythematosus	0.00089	0.027	CbGeAlD
Cytarabine—POLD1—Removal of DNA patch containing abasic residue—POLB—systemic lupus erythematosus	0.000858	0.0945	CbGpPWpGaD
Cytarabine—DCTD—nephron tubule—systemic lupus erythematosus	0.000838	0.0255	CbGeAlD
Cytarabine—POLD1—skin of body—systemic lupus erythematosus	0.000792	0.0241	CbGeAlD
Cytarabine—POLD1—Nucleotide Metabolism—POLB—systemic lupus erythematosus	0.000785	0.0864	CbGpPWpGaD
Cytarabine—POLD1—Base Excision Repair—POLB—systemic lupus erythematosus	0.000785	0.0864	CbGpPWpGaD
Cytarabine—POLB—lymphoid tissue—systemic lupus erythematosus	0.000785	0.0238	CbGeAlD
Cytarabine—DCTD—kidney—systemic lupus erythematosus	0.000737	0.0224	CbGeAlD
Cytarabine—DCTD—cortex of kidney—systemic lupus erythematosus	0.000717	0.0218	CbGeAlD
Cytarabine—POLB—bone marrow—systemic lupus erythematosus	0.000715	0.0217	CbGeAlD
Cytarabine—NT5E—connective tissue—systemic lupus erythematosus	0.000669	0.0203	CbGeAlD
Cytarabine—NT5E—nephron tubule—systemic lupus erythematosus	0.000648	0.0197	CbGeAlD
Cytarabine—POLB—lung—systemic lupus erythematosus	0.000648	0.0197	CbGeAlD
Cytarabine—POLD1—lymphoid tissue—systemic lupus erythematosus	0.000641	0.0195	CbGeAlD
Cytarabine—NT5E—skin of body—systemic lupus erythematosus	0.000604	0.0184	CbGeAlD
Cytarabine—POLB—nervous system—systemic lupus erythematosus	0.0006	0.0182	CbGeAlD
Cytarabine—DCTD—tendon—systemic lupus erythematosus	0.000595	0.0181	CbGeAlD
Cytarabine—Glucosamine—IFNG—systemic lupus erythematosus	0.000592	0.486	CrCbGaD
Cytarabine—POLB—central nervous system—systemic lupus erythematosus	0.000577	0.0175	CbGeAlD
Cytarabine—DCTD—bone marrow—systemic lupus erythematosus	0.000576	0.0175	CbGeAlD
Cytarabine—CDA—lymphoid tissue—systemic lupus erythematosus	0.000576	0.0175	CbGeAlD
Cytarabine—NT5E—kidney—systemic lupus erythematosus	0.00057	0.0173	CbGeAlD
Cytarabine—NT5E—cortex of kidney—systemic lupus erythematosus	0.000555	0.0169	CbGeAlD
Cytarabine—POLE—cortex of kidney—systemic lupus erythematosus	0.000544	0.0165	CbGeAlD
Cytarabine—CDA—tendon—systemic lupus erythematosus	0.000541	0.0164	CbGeAlD
Cytarabine—POLA1—Nucleotide Metabolism—POLB—systemic lupus erythematosus	0.00054	0.0595	CbGpPWpGaD
Cytarabine—POLD1—lung—systemic lupus erythematosus	0.000529	0.0161	CbGeAlD
Cytarabine—CDA—bone marrow—systemic lupus erythematosus	0.000524	0.0159	CbGeAlD
Cytarabine—DCTD—lung—systemic lupus erythematosus	0.000522	0.0159	CbGeAlD
Cytarabine—NT5E—lymphoid tissue—systemic lupus erythematosus	0.000489	0.0149	CbGeAlD
Cytarabine—CYP3A4—urine—systemic lupus erythematosus	0.000487	0.0148	CbGeAlD
Cytarabine—DCTD—nervous system—systemic lupus erythematosus	0.000483	0.0147	CbGeAlD
Cytarabine—POLE—lymphoid tissue—systemic lupus erythematosus	0.000479	0.0146	CbGeAlD
Cytarabine—DCTD—central nervous system—systemic lupus erythematosus	0.000465	0.0141	CbGeAlD
Cytarabine—NT5E—tendon—systemic lupus erythematosus	0.00046	0.014	CbGeAlD
Cytarabine—POLE—tendon—systemic lupus erythematosus	0.000451	0.0137	CbGeAlD
Cytarabine—NT5E—bone marrow—systemic lupus erythematosus	0.000446	0.0135	CbGeAlD
Cytarabine—POLE—bone marrow—systemic lupus erythematosus	0.000437	0.0133	CbGeAlD
Cytarabine—SLC22A2—nephron tubule—systemic lupus erythematosus	0.000408	0.0124	CbGeAlD
Cytarabine—NT5E—lung—systemic lupus erythematosus	0.000404	0.0123	CbGeAlD
Cytarabine—POLE—lung—systemic lupus erythematosus	0.000396	0.012	CbGeAlD
Cytarabine—POLB—DNA Repair—XRCC6—systemic lupus erythematosus	0.000393	0.0433	CbGpPWpGaD
Cytarabine—POLA1—tendon—systemic lupus erythematosus	0.000388	0.0118	CbGeAlD
Cytarabine—Glucosamine—MMP9—systemic lupus erythematosus	0.000378	0.31	CrCbGaD
Cytarabine—POLA1—bone marrow—systemic lupus erythematosus	0.000376	0.0114	CbGeAlD
Cytarabine—NT5E—nervous system—systemic lupus erythematosus	0.000374	0.0114	CbGeAlD
Cytarabine—POLE—nervous system—systemic lupus erythematosus	0.000366	0.0111	CbGeAlD
Cytarabine—SLC29A1—connective tissue—systemic lupus erythematosus	0.000365	0.0111	CbGeAlD
Cytarabine—NT5E—central nervous system—systemic lupus erythematosus	0.00036	0.0109	CbGeAlD
Cytarabine—SLC22A2—kidney—systemic lupus erythematosus	0.000358	0.0109	CbGeAlD
Cytarabine—POLE—central nervous system—systemic lupus erythematosus	0.000353	0.0107	CbGeAlD
Cytarabine—SLC22A2—cortex of kidney—systemic lupus erythematosus	0.000349	0.0106	CbGeAlD
Cytarabine—POLA1—lung—systemic lupus erythematosus	0.000341	0.0104	CbGeAlD
Cytarabine—DCK—nephron tubule—systemic lupus erythematosus	0.000338	0.0103	CbGeAlD
Cytarabine—SLC29A1—kidney—systemic lupus erythematosus	0.000311	0.00943	CbGeAlD
Cytarabine—SLC29A1—cortex of kidney—systemic lupus erythematosus	0.000302	0.00919	CbGeAlD
Cytarabine—DCK—cortex of kidney—systemic lupus erythematosus	0.000289	0.00878	CbGeAlD
Cytarabine—ABCC10—kidney—systemic lupus erythematosus	0.000283	0.00858	CbGeAlD
Cytarabine—ABCC10—cortex of kidney—systemic lupus erythematosus	0.000275	0.00836	CbGeAlD
Cytarabine—SLC29A1—lymphoid tissue—systemic lupus erythematosus	0.000267	0.0081	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000262	0.0288	CbGpPWpGaD
Cytarabine—DCK—lymphoid tissue—systemic lupus erythematosus	0.000255	0.00774	CbGeAlD
Cytarabine—CYP3A4—blood plasma—systemic lupus erythematosus	0.000254	0.00773	CbGeAlD
Cytarabine—SLC22A1—kidney—systemic lupus erythematosus	0.000253	0.00768	CbGeAlD
Cytarabine—SLC29A1—tendon—systemic lupus erythematosus	0.000251	0.00762	CbGeAlD
Cytarabine—Glucosamine—TNF—systemic lupus erythematosus	0.000248	0.204	CrCbGaD
Cytarabine—SLC29A1—bone marrow—systemic lupus erythematosus	0.000243	0.00738	CbGeAlD
Cytarabine—ABCC10—lymphoid tissue—systemic lupus erythematosus	0.000243	0.00737	CbGeAlD
Cytarabine—DCK—tendon—systemic lupus erythematosus	0.00024	0.00728	CbGeAlD
Cytarabine—DCK—bone marrow—systemic lupus erythematosus	0.000232	0.00705	CbGeAlD
Cytarabine—ABCC10—tendon—systemic lupus erythematosus	0.000228	0.00693	CbGeAlD
Cytarabine—ABCC10—bone marrow—systemic lupus erythematosus	0.000221	0.00671	CbGeAlD
Cytarabine—SLC29A1—lung—systemic lupus erythematosus	0.00022	0.00668	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000215	0.0236	CbGpPWpGaD
Cytarabine—DCK—lung—systemic lupus erythematosus	0.00021	0.00638	CbGeAlD
Cytarabine—SLC29A1—nervous system—systemic lupus erythematosus	0.000204	0.00619	CbGeAlD
Cytarabine—ABCC10—lung—systemic lupus erythematosus	0.0002	0.00608	CbGeAlD
Cytarabine—SLC29A1—central nervous system—systemic lupus erythematosus	0.000196	0.00596	CbGeAlD
Cytarabine—DCK—nervous system—systemic lupus erythematosus	0.000195	0.00591	CbGeAlD
Cytarabine—POLD1—DNA Repair—POLB—systemic lupus erythematosus	0.000189	0.0208	CbGpPWpGaD
Cytarabine—DCK—central nervous system—systemic lupus erythematosus	0.000187	0.00569	CbGeAlD
Cytarabine—POLE—DNA Repair—POLB—systemic lupus erythematosus	0.000182	0.0201	CbGpPWpGaD
Cytarabine—SLC22A1—nervous system—systemic lupus erythematosus	0.000166	0.00504	CbGeAlD
Cytarabine—SLC22A1—central nervous system—systemic lupus erythematosus	0.00016	0.00485	CbGeAlD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000154	0.0169	CbGpPWpGaD
Cytarabine—POLD1—DNA Repair—XRCC6—systemic lupus erythematosus	0.000151	0.0166	CbGpPWpGaD
Cytarabine—POLD1—Telomere Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000149	0.0165	CbGpPWpGaD
Cytarabine—POLE—DNA Repair—XRCC6—systemic lupus erythematosus	0.000146	0.016	CbGpPWpGaD
Cytarabine—POLE—Telomere Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000144	0.0159	CbGpPWpGaD
Cytarabine—POLD1—Chromosome Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000125	0.0137	CbGpPWpGaD
Cytarabine—POLE—Chromosome Maintenance—HIST2H2AC—systemic lupus erythematosus	0.00012	0.0132	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—GADD45A—systemic lupus erythematosus	0.000119	0.0132	CbGpPWpGaD
Cytarabine—CYP3A4—kidney—systemic lupus erythematosus	0.000115	0.0035	CbGeAlD
Cytarabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.000103	0.0114	CbGpPWpGaD
Cytarabine—POLA1—Telomere Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000103	0.0113	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	9.84e-05	0.0108	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—VEGFA—systemic lupus erythematosus	9.32e-05	0.0103	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	9.19e-05	0.0101	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	8.94e-05	0.00985	CbGpPWpGaD
Cytarabine—POLA1—Chromosome Maintenance—HIST2H2AC—systemic lupus erythematosus	8.57e-05	0.00944	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—TGFB1—systemic lupus erythematosus	8.55e-05	0.00942	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.8e-05	0.00859	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	7.63e-05	0.0084	CbGpPWpGaD
Cytarabine—CYP3A4—nervous system—systemic lupus erythematosus	7.56e-05	0.0023	CbGeAlD
Cytarabine—CYP3A4—central nervous system—systemic lupus erythematosus	7.28e-05	0.00221	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	7.22e-05	0.00795	CbGpPWpGaD
Cytarabine—POLD1—Danazol—Hydrocortisone—systemic lupus erythematosus	7.1e-05	0.0395	CbGdCrCtD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	6.55e-05	0.00721	CbGpPWpGaD
Cytarabine—NT5E—Differentiation Pathway—IL6—systemic lupus erythematosus	6.44e-05	0.0071	CbGpPWpGaD
Cytarabine—POLD1—Danazol—Prednisone—systemic lupus erythematosus	6.12e-05	0.034	CbGdCrCtD
Cytarabine—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	5.94e-05	0.00654	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	5.12e-05	0.00563	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	4.77e-05	0.00525	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—CDKN1B—systemic lupus erythematosus	4.65e-05	0.00512	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—HIST2H2AC—systemic lupus erythematosus	4.56e-05	0.00503	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—NAT2—systemic lupus erythematosus	4.56e-05	0.00502	CbGpPWpGaD
Cytarabine—POLA1—Norethindrone—Hydrocortisone—systemic lupus erythematosus	4.39e-05	0.0244	CbGdCrCtD
Cytarabine—POLE—G1 to S cell cycle control—CDKN1A—systemic lupus erythematosus	4.29e-05	0.00472	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	3.81e-05	0.0042	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	3.73e-05	0.0041	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	3.71e-05	0.00409	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	3.65e-05	0.00402	CbGpPWpGaD
Cytarabine—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	3.55e-05	0.00391	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	3.53e-05	0.00389	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	3.53e-05	0.00388	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	3.52e-05	0.00388	CbGpPWpGaD
Cytarabine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	3.52e-05	0.00387	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.51e-05	0.00387	CbGpPWpGaD
Cytarabine—POLA1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	3.49e-05	0.0194	CbGdCrCtD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	3.43e-05	0.00377	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—CDKN1B—systemic lupus erythematosus	3.42e-05	0.00377	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	3.41e-05	0.00376	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	3.37e-05	0.00371	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—CDKN1B—systemic lupus erythematosus	3.31e-05	0.00364	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	3.25e-05	0.00358	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—HIST2H2AC—systemic lupus erythematosus	3.25e-05	0.00358	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—CDKN1B—systemic lupus erythematosus	3.18e-05	0.00351	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	3.16e-05	0.00348	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—CDKN1A—systemic lupus erythematosus	3.16e-05	0.00348	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	3.13e-05	0.00344	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.08e-05	0.00339	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	3.05e-05	0.00336	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—CDKN1A—systemic lupus erythematosus	3.05e-05	0.00336	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CDKN1B—systemic lupus erythematosus	2.99e-05	0.0033	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—CDKN1A—systemic lupus erythematosus	2.94e-05	0.00324	CbGpPWpGaD
Cytarabine—POLE—S Phase—CDKN1B—systemic lupus erythematosus	2.89e-05	0.00318	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	2.89e-05	0.00318	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CDKN1A—systemic lupus erythematosus	2.76e-05	0.00304	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—EP300—systemic lupus erythematosus	2.75e-05	0.00302	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	2.72e-05	0.00299	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	2.68e-05	0.00296	CbGpPWpGaD
Cytarabine—POLE—S Phase—CDKN1A—systemic lupus erythematosus	2.67e-05	0.00294	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NAT2—systemic lupus erythematosus	2.62e-05	0.00288	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.6e-05	0.00286	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—RXRA—systemic lupus erythematosus	2.55e-05	0.00281	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.52e-05	0.00278	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	2.51e-05	0.00277	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	2.51e-05	0.00276	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.5e-05	0.00276	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	2.48e-05	0.00273	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Hydrocortisone—systemic lupus erythematosus	2.46e-05	0.0137	CbGdCrCtD
Cytarabine—POLA1—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	2.43e-05	0.00268	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.43e-05	0.00268	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	2.42e-05	0.00267	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NAT2—systemic lupus erythematosus	2.39e-05	0.00264	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—CDKN1B—systemic lupus erythematosus	2.36e-05	0.00259	CbGpPWpGaD
Cytarabine—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	2.34e-05	0.00258	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Methylprednisolone—systemic lupus erythematosus	2.32e-05	0.0129	CbGdCrCtD
Cytarabine—POLA1—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	2.32e-05	0.00255	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Dexamethasone—systemic lupus erythematosus	2.29e-05	0.0127	CbGdCrCtD
Cytarabine—DCK—Desoximetasone—Betamethasone—systemic lupus erythematosus	2.29e-05	0.0127	CbGdCrCtD
Cytarabine—POLA1—G1/S Transition—CDKN1B—systemic lupus erythematosus	2.27e-05	0.0025	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Methylprednisolone—systemic lupus erythematosus	2.25e-05	0.0125	CbGdCrCtD
Cytarabine—DCK—Desoximetasone—Triamcinolone—systemic lupus erythematosus	2.23e-05	0.0124	CbGdCrCtD
Cytarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.22e-05	0.00244	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Dexamethasone—systemic lupus erythematosus	2.22e-05	0.0123	CbGdCrCtD
Cytarabine—DCK—Diflorasone—Betamethasone—systemic lupus erythematosus	2.22e-05	0.0123	CbGdCrCtD
Cytarabine—POLA1—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	2.18e-05	0.0024	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—CDKN1A—systemic lupus erythematosus	2.17e-05	0.00239	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Triamcinolone—systemic lupus erythematosus	2.17e-05	0.0121	CbGdCrCtD
Cytarabine—DCK—Desoximetasone—Prednisone—systemic lupus erythematosus	2.12e-05	0.0118	CbGdCrCtD
Cytarabine—POLA1—G1/S Transition—CDKN1A—systemic lupus erythematosus	2.09e-05	0.00231	CbGpPWpGaD
Cytarabine—DCK—Desoximetasone—Prednisolone—systemic lupus erythematosus	2.07e-05	0.0115	CbGdCrCtD
Cytarabine—POLA1—S Phase—CDKN1B—systemic lupus erythematosus	2.06e-05	0.00227	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Prednisone—systemic lupus erythematosus	2.06e-05	0.0114	CbGdCrCtD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	2.02e-05	0.00223	CbGpPWpGaD
Cytarabine—DCK—Diflorasone—Prednisolone—systemic lupus erythematosus	2.01e-05	0.0112	CbGdCrCtD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.99e-05	0.00219	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	1.91e-05	0.00211	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CDKN1A—systemic lupus erythematosus	1.9e-05	0.00209	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	1.76e-05	0.00194	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PPARG—systemic lupus erythematosus	1.61e-05	0.00178	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.53e-05	0.00168	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NAT2—systemic lupus erythematosus	1.48e-05	0.00163	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—RXRA—systemic lupus erythematosus	1.47e-05	0.00162	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ALB—systemic lupus erythematosus	1.45e-05	0.0016	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.45e-05	0.0016	CbGpPWpGaD
Cytarabine—DCK—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	1.44e-05	0.008	CbGdCrCtD
Cytarabine—ABCC10—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.42e-05	0.00157	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	1.42e-05	0.00156	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	1.41e-05	0.00155	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NAT2—systemic lupus erythematosus	1.4e-05	0.00154	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—NOS3—systemic lupus erythematosus	1.39e-05	0.00153	CbGpPWpGaD
Cytarabine—CDA—Metabolism—RXRA—systemic lupus erythematosus	1.34e-05	0.00148	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.34e-05	0.00147	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.27e-05	0.0014	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—systemic lupus erythematosus	1.27e-05	0.0014	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.2e-05	0.00133	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.15e-05	0.00126	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.13e-05	0.00124	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.11e-05	0.00122	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	1.09e-05	0.0012	CbGpPWpGaD
Cytarabine—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.07e-05	0.00118	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—EP300—systemic lupus erythematosus	1.06e-05	0.00116	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.03e-05	0.00114	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	1.02e-05	0.00112	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	9.84e-06	0.00108	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	9.41e-06	0.00104	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PPARG—systemic lupus erythematosus	9.26e-06	0.00102	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN1B—systemic lupus erythematosus	9.11e-06	0.001	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	9.08e-06	0.001	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	8.95e-06	0.000986	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN1B—systemic lupus erythematosus	8.8e-06	0.000969	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	8.64e-06	0.000952	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PPARG—systemic lupus erythematosus	8.47e-06	0.000933	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN1A—systemic lupus erythematosus	8.41e-06	0.000926	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ALB—systemic lupus erythematosus	8.33e-06	0.000917	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—RXRA—systemic lupus erythematosus	8.32e-06	0.000917	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN1A—systemic lupus erythematosus	8.12e-06	0.000894	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—EP300—systemic lupus erythematosus	8e-06	0.000881	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—NOS3—systemic lupus erythematosus	7.97e-06	0.000877	CbGpPWpGaD
Cytarabine—DCK—Metabolism—RXRA—systemic lupus erythematosus	7.83e-06	0.000862	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—EP300—systemic lupus erythematosus	7.73e-06	0.000851	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ALB—systemic lupus erythematosus	7.62e-06	0.000839	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	7.39e-06	0.000814	CbGpPWpGaD
Cytarabine—CDA—Metabolism—NOS3—systemic lupus erythematosus	7.29e-06	0.000802	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—systemic lupus erythematosus	7.29e-06	0.000802	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	7.01e-06	0.000772	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.89e-06	0.000759	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—systemic lupus erythematosus	6.66e-06	0.000734	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.62e-06	0.000729	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	6.47e-06	0.000713	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1B—systemic lupus erythematosus	6.27e-06	0.000691	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.17e-06	0.000679	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	6.16e-06	0.000678	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	6.1e-06	0.000672	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—EP300—systemic lupus erythematosus	6.06e-06	0.000667	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN1A—systemic lupus erythematosus	5.79e-06	0.000637	CbGpPWpGaD
Cytarabine—CDA—Metabolism—EP300—systemic lupus erythematosus	5.54e-06	0.00061	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NAT2—systemic lupus erythematosus	5.53e-06	0.000609	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—EP300—systemic lupus erythematosus	5.51e-06	0.000606	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PPARG—systemic lupus erythematosus	5.26e-06	0.000579	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NAT2—systemic lupus erythematosus	5.15e-06	0.000567	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PPARG—systemic lupus erythematosus	4.94e-06	0.000544	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ALB—systemic lupus erythematosus	4.73e-06	0.00052	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—NOS3—systemic lupus erythematosus	4.52e-06	0.000498	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ALB—systemic lupus erythematosus	4.44e-06	0.000489	CbGpPWpGaD
Cytarabine—DCK—Metabolism—NOS3—systemic lupus erythematosus	4.25e-06	0.000468	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—systemic lupus erythematosus	4.13e-06	0.000455	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—systemic lupus erythematosus	3.89e-06	0.000428	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.76e-06	0.000414	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.5e-06	0.000386	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—EP300—systemic lupus erythematosus	3.44e-06	0.000379	CbGpPWpGaD
Cytarabine—DCK—Metabolism—EP300—systemic lupus erythematosus	3.23e-06	0.000356	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—RXRA—systemic lupus erythematosus	3.1e-06	0.000341	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—RXRA—systemic lupus erythematosus	2.89e-06	0.000318	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PPARG—systemic lupus erythematosus	1.96e-06	0.000215	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.86e-06	0.000205	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PPARG—systemic lupus erythematosus	1.82e-06	0.000201	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ALB—systemic lupus erythematosus	1.76e-06	0.000194	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—NOS3—systemic lupus erythematosus	1.68e-06	0.000185	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ALB—systemic lupus erythematosus	1.64e-06	0.000181	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—NOS3—systemic lupus erythematosus	1.57e-06	0.000173	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—systemic lupus erythematosus	1.54e-06	0.00017	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—systemic lupus erythematosus	1.43e-06	0.000158	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—EP300—systemic lupus erythematosus	1.28e-06	0.000141	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—EP300—systemic lupus erythematosus	1.19e-06	0.000131	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.04e-06	0.000115	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	6.59e-07	7.25e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	5.92e-07	6.52e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	5.66e-07	6.24e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	5.18e-07	5.71e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	4.31e-07	4.75e-05	CbGpPWpGaD
